Thus, a dysfunctional Plin4/LD/mitophagy axis is clarified to be involved in PD pathophysiology, indicating that Plin4-LD changes in the brain may be a promising biomarker as well as therapeutic target for PD. The gene discussed is PLIN4; the disease is Parkinson disease.